טוען...
Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
BACKGROUND: The U.S. Physician Payments Sunshine Act mandates the reporting of payments or items of value received by physicians from drug, medical device, and biological agent manufacturers. The impact of these payments on physician prescribing has not been examined at large scale. METHODS: We link...
שמור ב:
| הוצא לאור ב: | PLoS One |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4868346/ https://ncbi.nlm.nih.gov/pubmed/27183221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0155474 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|